UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeting the PD-1 pathway in pediatric solid tumors and brain tumors

OncoTargets and therapy, 2017-01, Vol.10, p.2097-2106

2017

Volltextzugriff (PDF)

Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS‐BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment

Journal of the American Heart Association, 2018-03, Vol.7 (6), p.n/a

2018

Volltextzugriff (PDF)

Vena Cava Filter Retrieval Rates and Factors Associated With Retrieval in a Large US Cohort

Journal of the American Heart Association, 2017-09, Vol.6 (9), p.n/a

2017

Volltextzugriff (PDF)

Doxorubicin and Paclitaxel-Loaded Lipid-Based Nanoparticles Overcome Multidrug Resistance by Inhibiting P-Glycoprotein and Depleting ATP

Cancer research (Chicago, Ill.), 2009-05, Vol.69 (9), p.3918-3926

2009

Volltextzugriff (PDF)

Sticky Issues: What APs Need to Know About Anticoagulants and Patients With Cancer

Journal of the advanced practitioner in oncology, 2021-04, Vol.12 (3), p.262-265

2021

Volltextzugriff (PDF)

Age Adjusted Comorbidity Risk Index Does Not Predict Outcomes in an Autologous Hematopoietic Stem Cell Transplant Population

Cell transplantation, 2022-02, Vol.31, p.9636897221080385-9636897221080385

2022

Volltextzugriff (PDF)

Statin use and venous thromboembolism in cancer: A large, active comparator, propensity score matched cohort study

Thrombosis research, 2017-10, Vol.158, p.49-58

2017

Volltextzugriff (PDF)

Incidence and Risk Factors of Thromboembolism with Multiple Myeloma in the Presence of Death as a Competing Risk: An Empirical Comparison of Statistical Methodologies

Healthcare (Basel), 2016-02, Vol.4 (1), p.16

2016

Volltextzugriff (PDF)

Impact of Time-Varying Treatment Exposures on the Risk of Venous Thromboembolism in Multiple Myeloma

Healthcare (Basel), 2016-12, Vol.4 (4), p.93

2016

Volltextzugriff (PDF)

Concurrent Everolimus With Hepatic Transarterial Bland Embolotherapy in Patients With Metastatic Well-Differentiated Neuroendocrine Tumors

Oncology (Williston Park, N.Y.), 2020-11, Vol.34 (11), p.471

2020

Volltextzugriff (PDF)

Competing Risks Analysis of Cancer-associated Recurrent Thrombosis, Major Bleeds, and Death in a Geriatric Cohort

Journal of health economics and outcomes research (Online), 2015-12, Vol.4 (1), p.1-18

2015

Volltextzugriff (PDF)

Multiple sclerosis outcomes after cancer immunotherapy

Clinical & translational oncology, 2019-10, Vol.21 (10), p.1336-1342

2019

Volltextzugriff (PDF)

Prescribing Characteristics of Octreotide Immediate-Release and Long-Acting Release in Patients with Neuroendocrine Tumors

The oncologist (Dayton, Ohio), 2023-06, Vol.28 (6), p.479-485

2023

Volltextzugriff (PDF)

Anticancer Activity of Novel Unnatural Synthetic Isoprenoids

Anticancer research, 2010-07, Vol.30 (7), p.2505-2512

2010

Volltextzugriff (PDF)

Complications associated with treatment of malignancies: a focus on avascular necrosis of the bone

Orthopedics (Thorofare, N.J.), 2010-06, Vol.33 (6), p.413-416

2010

Volltextzugriff (PDF)

NCMP-02. MULTIPLE SCLEROSIS OUTCOMES AFTER CANCER IMMUNOTHERAPY

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi194-vi194

2018

Volltextzugriff (PDF)

An important recent development in cancer research has been the identification of new genetic and molecular tumor profiling techniques. Introduction

American journal of health-system pharmacy, 2010-01, Vol.67 (1 Suppl 1), p.S1-S2

2010

Volltextzugriff (PDF)

Abstract CT067: A Phase I study of Fosbretabulin in combination with everolimus in neuroendocrine tumors (Grades 1-3) that have progressed after at least one prior regimen for metastatic disease

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.CT067-CT067

2019

Volltextzugriff (PDF)

Osteonecrosis of the jaw associated with bisphosphonate therapy

Orthopedics (Thorofare, N.J.), 2009-12, Vol.32 (12), p.900-903

2009

Volltextzugriff (PDF)

Priming immunotherapy with radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC) and head and neck squamous cell cancer (HNSCC): Interim analysis of phase II clinical trial

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.2628-2628

2021

Volltextzugriff (PDF)

The influence of antidiabetic medications on the development and progression of prostate cancer

Cancer epidemiology, 2012-08, Vol.36 (4), p.e243-e250

2012

Volltextzugriff (PDF)

Antitumor efficacy of concurrent everolimus with hepatic transarterial bland embolization (evero-embo) in patients with metastatic well differentiated neuroendocrine tumor (NET)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4115-4115

2019

Volltextzugriff (PDF)

Concurrent Everolimus With Hepatic Transarterial Bland Embolotherapy

Oncology (Williston Park, N.Y.), 2020-11, Vol.34 (11), p.471

2020

Volltextzugriff (PDF)

Clinical efficacy and toxicity data on phase I study of fosbretabulin in combination with everolimus in neuroendocrine tumors

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4114-4114

2019

Volltextzugriff (PDF)

L-Canavanine as a radiosensitization agent for human pancreatic cancer cells

Molecular and cellular biochemistry, 2003-02, Vol.244 (1-2), p.37-43

2003

Volltextzugriff (PDF)

1 – 25 von 206

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(188)

Publikationsform

Sprache

Englisch
(204)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(34)
Humans
(27)
Female
(14)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Male
(12)
Oncology
(10)
Middle Aged
(9)
Adult
(6)
Aged
(6)
Cancer
(6)
Multiple Myeloma
(6)
Breast Cancer
(5)
Metastasis
(5)
Retrospective Studies
(5)
Venous Thromboembolism
(5)
Antineoplastic Agents - Adverse Effects
(4)
Bisphosphonates
(4)
Cancer Therapies
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Targeting the PD-1 pathway in pediatric solid tumors and brain tumors

Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS‐BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment

Vena Cava Filter Retrieval Rates and Factors Associated With Retrieval in a Large US Cohort

Doxorubicin and Paclitaxel-Loaded Lipid-Based Nanoparticles Overcome Multidrug Resistance by Inhibiting P-Glycoprotein and Depleting ATP

Sticky Issues: What APs Need to Know About Anticoagulants and Patients With Cancer

Age Adjusted Comorbidity Risk Index Does Not Predict Outcomes in an Autologous Hematopoietic Stem Cell Transplant Population

Statin use and venous thromboembolism in cancer: A large, active comparator, propensity score matched cohort study

Incidence and Risk Factors of Thromboembolism with Multiple Myeloma in the Presence of Death as a Competing Risk: An Empirical Comparison of Statistical Methodologies

Impact of Time-Varying Treatment Exposures on the Risk of Venous Thromboembolism in Multiple Myeloma

Concurrent Everolimus With Hepatic Transarterial Bland Embolotherapy in Patients With Metastatic Well-Differentiated Neuroendocrine Tumors

Competing Risks Analysis of Cancer-associated Recurrent Thrombosis, Major Bleeds, and Death in a Geriatric Cohort

Multiple sclerosis outcomes after cancer immunotherapy

Prescribing Characteristics of Octreotide Immediate-Release and Long-Acting Release in Patients with Neuroendocrine Tumors

Anticancer Activity of Novel Unnatural Synthetic Isoprenoids

Complications associated with treatment of malignancies: a focus on avascular necrosis of the bone

NCMP-02. MULTIPLE SCLEROSIS OUTCOMES AFTER CANCER IMMUNOTHERAPY

An important recent development in cancer research has been the identification of new genetic and molecular tumor profiling techniques. Introduction

Abstract CT067: A Phase I study of Fosbretabulin in combination with everolimus in neuroendocrine tumors (Grades 1-3) that have progressed after at least one prior regimen for metastatic disease

Osteonecrosis of the jaw associated with bisphosphonate therapy

Priming immunotherapy with radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC) and head and neck squamous cell cancer (HNSCC): Interim analysis of phase II clinical trial

The influence of antidiabetic medications on the development and progression of prostate cancer

Antitumor efficacy of concurrent everolimus with hepatic transarterial bland embolization (evero-embo) in patients with metastatic well differentiated neuroendocrine tumor (NET)

Concurrent Everolimus With Hepatic Transarterial Bland Embolotherapy

Clinical efficacy and toxicity data on phase I study of fosbretabulin in combination with everolimus in neuroendocrine tumors

L-Canavanine as a radiosensitization agent for human pancreatic cancer cells

Aktive Filter

Suchergebnisse filtern